Investigational drug · Phase 2
BI 3802876
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Liver Cirrhosis.
Phase 2Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
2
Any phase or sponsor naming "BI 3802876"
First trial start
2026
Feb 27, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "BI 3802876", any sponsor or status.
Conditions studied
As listed on its trial records.
- Liver Cirrhosis
Approved drugs for the same conditions: Gastroenterology and liver
Largest trials
Live from ClinicalTrials.gov: studies naming "BI 3802876" as an intervention, largest first.
Boehringer IngelheimBoehringer Ingelheim
NCT06081530 · 59 participants · Start Oct 27, 2023 · Primary completion Mar 20, 2025
Drug: BI 3802876; Placebo matching BI 3802876 · For: Healthy
Sites: Edegem, Belgium
Boehringer IngelheimBoehringer Ingelheim
NCT07325526 · 30 participants (planned) · Start Feb 27, 2026 · Primary completion Aug 5, 2027
Drug: BI 3802876; Placebo · For: Liver Cirrhosis
Sites: Chandler, Arizona; Coronado, California; La Mesa, California · 28 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from Boehringer Ingelheim.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.